Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed

Journal of Pharmacology and Experimental Therapeutics

Volumn 311, Issue 1, 2004, Pages 411-419

  Duncan, Marnie ^a   Kendall, David A ^a   Ralevic, Vera ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CAPSAICIN; DEXANABINOL; DRONABINOL; GUANETHIDINE; RIMONABANT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; EVOKED RESPONSE; MALE; MESENTERIC ARTERY; NERVE CONDUCTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SENSORY SYSTEM; VASODILATATION;

ANIMALS; BENZOFURANS; BORNANES; CALCITONIN GENE-RELATED PEPTIDE; CANNABINOIDS; CAPSAICIN; CYCLOHEXANOLS; ELECTRIC STIMULATION; INDOLES; MALE; MESENTERIC ARTERIES; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; TETRAHYDROCANNABINOL; VASODILATION;

EID: 4644260469     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.067587     Document Type: Article

References (28)

1. Breivogel CS, Griffin G, Di Marzo V, and Martin BR (2001) Evidence for a new G protein coupled cannabinoid receptor in the mouse brain. Mol Pharmacol 60:155-163.
2. Calignano A, La Rana G, and Piomelli D (2001) Antinociceptive activity of the endogenous fatty acid amide, palmitoylethanolamide. Eur J Pharmacol 419:191-198.
3. 2 receptor-mediated actions of anandamide in the mouse brain. J Neurochem 75:2434-2444.
4. Duncan M, Kendall DA, and Ralevic V (2003) The effects of ruthenium red on the inhibitory actions of noladin ether, THC and HU210 on sensory neurotransmission in the rat isolated mesenteric arterial bed. 1st European Workshop on Cannabinoid Research; 2003 Apr 4-5; Madrid, Spain, http://www.ucm.es/info/seic-web/abstract-book.pdf
5. i/o linked receptor. Br J Pharmacol 142:509-518.
6. Ellington HC, Cotter MA, Cameron NE, and Ross RA (2002) The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats. Neuropharmacology 42:966-975.
7. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, and Leon A (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376-3380.
8. 2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol 339:53-61.
9. Hajos N, Ledent C, and Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamateric synaptic transmission in the hippocampus. Neuroscience 106:1-4.
10. Han SP, Naes L, and Westfall TC (1990) Inhibition of periarterial nerve stimulation-induced vasodilation of the mesenteric arterial bed by CGRP (8-37) and CGRP receptor desensitization. Biochem Biophys Res Commun 168:786-791.
11. 2, a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 96:14228-14233.
12. Hohmann AG and Herkenham M (1999) Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience 92:1171-1175.
13. Howlett AC, Earth F, Bonner TI, Cabral G, Casellass P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
14. 2 receptors. Proc Natl Acad Sci USA 96:14136-14141.
15. Kawasaki H, Takasaki K, Saito A, and Goto K (1988) Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature (Lond) 335:164-167.
16. Maggi CA and Meli A (1988) The sensory-efferent function of capsaicin-sensitive neurons. Gen Pharmacol 19:1-43.
17. Monory K, Tzavara EH, Lexime J, Ledent C, Parmentier M, Borsodi A, and Hanoune J (2002) Novel, non-adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice. Biochem Biophys Res Commun 292:231-235.
18. Pertwee RG (1999) Pharmacology of cannabinoid receptor ligands Curr Med Chem 6:635-664.
19. Ralevic V, Aberdeen JA, and Burnstock G (1991) Acrylamide-induced autonomic neuropathy of rat mesenteric vessels: histological and pharmacological studies. J Auton Nerv Syst 34:77-88.
20. Ralevic V and Kendall DA (2001) Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmitter in the rat isolated mesenteric arterial bed. Eur J Pharmacol 418:117-125.
21. Richardson JD, Aanonsen L, and Hargreaves KM (1998a) Antihyperalgersic effects of spinal cannabinoids. Eur J Pharmacol 345:145-153.
22. 1 receptors. Pain 75:111-119.
23. Ross RA, Coutts AA, McFarlane SM, Anavi-Goffer S, Irving AJ, Pertwee RG, MacEwan DJ, and Scott RH (2001) Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology 40:221-232.
24. Wagner JA, Varga K, and Kunos G (1998) Cardiovascular actions of cannabinoids and their generation during shock. J Mol Med 76:824-836.
25. Welch SP, Huffman JW, and Lowe J (1998) Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J Pharmacol Exp Ther 286:1301-1308.
26. White R and Hiley CR (1998) The actions of come cannabinoid receptor ligands in the rat isolated mesenteric artery. Br J Pharmacol 125:533-541.
27. 2 cannabinoid receptor-independent mechanism. J Neurosci 22:4720-4727.
28. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgard M, Di Marzo V, Julius D, and Högestätt ED (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (Lond) 400:452-456.